158 related articles for article (PubMed ID: 37737056)
1. A novel prediction model of the risk of pancreatic cancer among diabetes patients using multiple clinical data and machine learning.
Chen SM; Phuc PT; Nguyen PA; Burton W; Lin SJ; Lin WC; Lu CY; Hsu MH; Cheng CT; Hsu JC
Cancer Med; 2023 Oct; 12(19):19987-19999. PubMed ID: 37737056
[TBL] [Abstract][Full Text] [Related]
2. Prediction of 3-year risk of diabetic kidney disease using machine learning based on electronic medical records.
Dong Z; Wang Q; Ke Y; Zhang W; Hong Q; Liu C; Liu X; Yang J; Xi Y; Shi J; Zhang L; Zheng Y; Lv Q; Wang Y; Wu J; Sun X; Cai G; Qiao S; Yin C; Su S; Chen X
J Transl Med; 2022 Mar; 20(1):143. PubMed ID: 35346252
[TBL] [Abstract][Full Text] [Related]
3. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
[TBL] [Abstract][Full Text] [Related]
4. Machine Learning for the Prediction of New-Onset Diabetes Mellitus during 5-Year Follow-up in Non-Diabetic Patients with Cardiovascular Risks.
Choi BG; Rha SW; Kim SW; Kang JH; Park JY; Noh YK
Yonsei Med J; 2019 Feb; 60(2):191-199. PubMed ID: 30666841
[TBL] [Abstract][Full Text] [Related]
5. Prediction of pancreatic cancer risk in patients with new-onset diabetes using a machine learning approach based on routine biochemical parameters.
Cichosz SL; Jensen MH; Hejlesen O; Henriksen SD; Drewes AM; Olesen SS
Comput Methods Programs Biomed; 2024 Feb; 244():107965. PubMed ID: 38070389
[TBL] [Abstract][Full Text] [Related]
6. Unveiling the future of COVID-19 patient care: groundbreaking prediction models for severe outcomes or mortality in hospitalized cases.
Hien NTK; Tsai FJ; Chang YH; Burton W; Phuc PT; Nguyen PA; Harnod D; Lam CS; Lu TC; Chen CI; Hsu MH; Lu CY; Huang CW; Yang HC; Hsu JC
Front Med (Lausanne); 2023; 10():1289968. PubMed ID: 38249981
[TBL] [Abstract][Full Text] [Related]
7. Risk Prediction of Pancreatic Cancer in Patients With Recent-onset Hyperglycemia: A Machine-learning Approach.
Chen W; Butler RK; Lustigova E; Chari ST; Maitra A; Rinaudo JA; Wu BU
J Clin Gastroenterol; 2023 Jan; 57(1):103-110. PubMed ID: 35470312
[TBL] [Abstract][Full Text] [Related]
8. Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.
Cui Y; Shi X; Wang S; Qin Y; Wang B; Che X; Lei M
Front Public Health; 2022; 10():1019168. PubMed ID: 36276398
[TBL] [Abstract][Full Text] [Related]
9. Explainable Machine Learning Techniques To Predict Amiodarone-Induced Thyroid Dysfunction Risk: Multicenter, Retrospective Study With External Validation.
Lu YT; Chao HJ; Chiang YC; Chen HY
J Med Internet Res; 2023 Feb; 25():e43734. PubMed ID: 36749620
[TBL] [Abstract][Full Text] [Related]
10. Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study.
Liu XZ; Duan M; Huang HD; Zhang Y; Xiang TY; Niu WC; Zhou B; Wang HL; Zhang TT
Front Endocrinol (Lausanne); 2023; 14():1184190. PubMed ID: 37469989
[TBL] [Abstract][Full Text] [Related]
11. Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.
Woldaregay AZ; Årsand E; Walderhaug S; Albers D; Mamykina L; Botsis T; Hartvigsen G
Artif Intell Med; 2019 Jul; 98():109-134. PubMed ID: 31383477
[TBL] [Abstract][Full Text] [Related]
12. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
[TBL] [Abstract][Full Text] [Related]
13. A machine learning prediction model for cancer risk in patients with type 2 diabetes based on clinical tests.
Qiu B; Chen H; Zhang E; Ma F; An G; Zong Y; Shang L; Zhang Y; Zhu H
Technol Health Care; 2024; 32(3):1431-1443. PubMed ID: 37781827
[TBL] [Abstract][Full Text] [Related]
14. Machine learning versus regression for prediction of sporadic pancreatic cancer.
Chen W; Zhou B; Jeon CY; Xie F; Lin YC; Butler RK; Zhou Y; Luong TQ; Lustigova E; Pisegna JR; Wu BU
Pancreatology; 2023 Jun; 23(4):396-402. PubMed ID: 37130760
[TBL] [Abstract][Full Text] [Related]
15. Machine learning for the prediction of atherosclerotic cardiovascular disease during 3-year follow up in Chinese type 2 diabetes mellitus patients.
Ding J; Luo Y; Shi H; Chen R; Luo S; Yang X; Xiao Z; Liang B; Yan Q; Xu J; Ji L
J Diabetes Investig; 2023 Nov; 14(11):1289-1302. PubMed ID: 37605871
[TBL] [Abstract][Full Text] [Related]
16. Genetic Risk Score Increased Discriminant Efficiency of Predictive Models for Type 2 Diabetes Mellitus Using Machine Learning: Cohort Study.
Wang Y; Zhang L; Niu M; Li R; Tu R; Liu X; Hou J; Mao Z; Wang Z; Wang C
Front Public Health; 2021; 9():606711. PubMed ID: 33681127
[No Abstract] [Full Text] [Related]
17. Predicting Fetal Alcohol Spectrum Disorders Using Machine Learning Techniques: Multisite Retrospective Cohort Study.
Oh SS; Kuang I; Jeong H; Song JY; Ren B; Moon JY; Park EC; Kawachi I
J Med Internet Res; 2023 Jul; 25():e45041. PubMed ID: 37463016
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Atrial Fibrillation in Hospitalized Elderly Patients With Coronary Heart Disease and Type 2 Diabetes Mellitus Using Machine Learning: A Multicenter Retrospective Study.
Xu Q; Peng Y; Tan J; Zhao W; Yang M; Tian J
Front Public Health; 2022; 10():842104. PubMed ID: 35309227
[TBL] [Abstract][Full Text] [Related]
19. Implementation of five machine learning methods to predict the 52-week blood glucose level in patients with type 2 diabetes.
Fu X; Wang Y; Cates RS; Li N; Liu J; Ke D; Liu J; Liu H; Yan S
Front Endocrinol (Lausanne); 2022; 13():1061507. PubMed ID: 36743935
[TBL] [Abstract][Full Text] [Related]
20. Machine Learning to Identify Predictors of Glycemic Control in Type 2 Diabetes: An Analysis of Target HbA1c Reduction Using Empagliflozin/Linagliptin Data.
Del Parigi A; Tang W; Liu D; Lee C; Pratley R
Pharmaceut Med; 2019 Jun; 33(3):209-217. PubMed ID: 31933292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
